who makes the glp 1 drugs Comparing Ozempic, Wegovy and Other GLP-1 GLP-1 Costs Explained: Managing Coverage

Additionally, cost-effectiveness analyses have shown that current GLP-1 pricing does not align with accepted value thresholds, making health systems less likely to support broad reimbursement

High costs serve as barrier to care High out-of-pocket costs for people without insurance coverage remain a key factor in determining who can benefit from GLP-1 medications and who cannot, said Tracy Svenyach, PhD, director of policy strategy and alliance at the Obesity Action Coalition

Home monitoring tools for GLP-1 therapy can help track progress and identify issues early

Additionally, 3041% of participants in the higher-dose groups discontinued at least one antihypertensive medication

Is weight loss a goal

Copyright: The Author(s) 2023